Ropivacaine as a novel AKT1 specific inhibitor regulates the stemness of breast cancer

Lin Ding(Sun Yat-sen University), Yong‐Guan Zhu(Institute of Urban Environment)
Journal of Experimental & Clinical Cancer Research
March 25, 2024
Cited by 10


Related Papers